Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 1

Status

Active not recruiting 2Recruiting 1Completed 1

Sponsor Class

NIH 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4

Conditions

Squamous Cell Carcinoma of Head and Neck 7Oropharyngeal Neoplasms 7Carcinoma 6Lung Neoplasms 5Nasopharyngeal Carcinoma 4Mouth Neoplasms 4Laryngeal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Urinary Bladder Neoplasms 3Mesothelioma, Malignant 3Lymphoid Interstitial Pneumonia 3Hypopharyngeal Neoplasms 3Uterine Cervical Neoplasms 2Pancreatic Neoplasms 2Ganglioneuroblastoma 2Adenocarcinoma of Lung 2Vulvar Neoplasms 1Vaginal Neoplasms 1Tongue Neoplasms 1Solitary Fibrous Tumor, Pleural 1Sinonasal Squamous Cell Carcinoma 1Salivary Gland Neoplasms 1Resectable Intrahepatic Cholangiocarcinoma 1Renal Pelvis and Ureter Urothelial Carcinoma 1Osteosarcoma 1Neuroblastoma 1Mesothelioma 1Medulloblastoma 1Locally Advanced Cervical Adenocarcinoma 1Liver Neoplasms 1

Interventions

Carboplatin 71pembrolizumab 70Pemetrexed 62Cisplatin 46Nivolumab 28Paclitaxel 27durvalumab 26Specimen Handling 25osimertinib 23Docetaxel 23Magnetic Resonance Spectroscopy 21Gemcitabine 17Cetuximab 15130-nm albumin-bound paclitaxel 15atezolizumab 14amivantamab 14Radiotherapy 12Radiosurgery 12lazertinib 11Ipilimumab 9Bevacizumab 9cemiplimab 8Taxes 8Drug Therapy 8alectinib 7Ramucirumab 7Observation 7Radiation 6Leucovorin 5Immunoglobulin G 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × 1,2-diaminocyclohexaneplatinum II citrate × 30 days × Clear all
NCT04267848 2026-06-03

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

National Cancer Institute (NCI)

Phase 3 Recruiting
1,210 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02194738 2026-05-29

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

National Cancer Institute (NCI)

Phase NA Active not recruiting
8,300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04092283 2026-05-29

Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
660 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01993810 2026-05-27

Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer

Radiation Therapy Oncology Group

Phase 3 Completed
330 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡